Compare Hormel Foods Corp (HRL) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hormel Foods Corp vs Revvity Inc — how do they compare? Hormel Foods Corp trades at $20.57 (market cap $10.90B), while Revvity Inc trades at $155 (market cap $16.97B). The key difference: Revvity Inc is the larger of the two by market cap, and Hormel Foods Corp pays the higher dividend (5.91%). Which is the better fit depends on your goals — on Pluang, investors hold Hormel Foods Corp for 99 Days and Revvity Inc for 13 Days on average.
| HRL | RVTY | |
|---|---|---|
Market Cap | $10.90B | $16.97B |
Volume | 5,843,624 | 1,602,713 |
Sector | Consumer Staples | Health |
52-Week High | $26.50 | $157.36 |
52-Week Low | $19.19 | $82.26 |
Typical Hold Time | 99 Days | 13 Days |
Enterprise Value | $12.89B | $19.29B |
Dividend Yield | 5.91% | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hormel Foods (HRL) trades at $19.21, down 0.47% on the day, with a bearish technical signal and neutral oscillators. The company reported revenue of $12.11B for 2025, but net income fell to $478.20M, reducing the profit margin to 3.95%. Recent news highlights the $1.06B acquisition of Brakebush to expand its chicken business, while the dividend yield remains a key attraction with a 60-year streak of increases.
The outlook is mixed: analyst consensus is a 'Hold' with a $25.00 price target, implying upside, but risks include margin pressure and high payout ratios. Growth depends on successful integration of acquisitions and navigating cost inflation, making the stock a cautious hold for income-focused investors amid fundamental challenges.
RVTY trades at $155.08, down 0.34% today but near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving average support. Recent earnings beats and a Zacks upgrade to Buy reflect positive momentum. The company launched a new Type 1 diabetes screening kit in Europe and announced the acquisition of Human Cell Design, expanding its metabolic disease research tools.
Outlook remains positive with revenue stability and margin pressures manageable. Investment opportunity lies in diagnostic growth and AI-driven demand, though premium valuation and China market risks warrant caution. The absence of sell ratings and strong institutional accumulation support a constructive view, but rich multiples require sustained earnings delivery for further upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
